Apricus Biosciences Inc Stock Nasdaq
Equities
US03832V3078
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | 2.2 | Capitalization | 13.61M |
---|---|---|---|---|---|
Net income 2022 | -73M | Net income 2023 | -37M | EV / Sales 2022 | - |
Net Debt 2022 | 4.59M | Net Debt 2023 | 11.23M | EV / Sales 2023 | 11,278,477 x |
P/E ratio 2022 |
-0.98
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98% |
Latest transcript on Apricus Biosciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 64 | 86-12-31 |
Director of Finance/CFO | 52 | 18-12-31 | |
Karen Fusaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 21-08-31 | |
Richard Pascoe
BRD | Director/Board Member | 60 | 13-02-28 |
Daniel O'Connor
BRD | Director/Board Member | 59 | 18-12-31 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-9.37% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |